Fluminorex
From Wikipedia, the free encyclopedia
|
Fluminorex
|
|
| Systematic (IUPAC) name | |
| 5-[4-(trifluoromethyl)phenyl]-4,5-dihydro-1,3-oxazol-2-amine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C10H9F3N2O |
| Mol. mass | 230.19 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Fluminorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant.

